Chapman C J, Wright D, Stevenson F K
Molecular Immunology Group, Tenovus Laboratory, Southampton University Hospitals, UK.
Leuk Lymphoma. 1998 Jul;30(3-4):257-67. doi: 10.3109/10428199809057539.
Analysis of usage of V(H) and V(L) genes, and the degree and pattern of somatic mutation, has been used to investigate the cell of origin and clonal history in cases of Burkitt's lymphoma (BL). Tumor cell lines and biopsy material from patients with endemic, sporadic and AIDS-associated BL have been compared. V(H) genes were most commonly derived from the V(H)3 (52%) and V(H)4 (39%) families. This shows a similar gene usage of the V(H)3 family to that seen in the normal peripheral blood repertoire (55%), but a biased usage of the V(H)4 family (22% in normal). There was no restriction in V(L) gene usage. This overall distribution was similar in all subsets of BL. In all categories, there was significant somatic mutation in both V(H) and V(L) sequences. There was no evidence for accumulation of mutations in cell lines cultured in vitro indicating that all mutations in BL-derived cell lines have accumulated in vivo. The mean percentage level of mutation +/- standard deviation was greater in endemic BL (V(H) = 7.7 +/- 4.0, V(L) = 5.3 +/- 2.2) and AIDS-associated BL (V(H) = 7.5 +/- 3.6, V(L) = 3.9 +/- 1.9) than in sporadic BL (V(H) = 4.0 +/- 2.5, V(L) = 2.2 +/- 1.2). The pattern of somatic hypermutation was similar in V(H) and V(L) sequences of the different types of BL although the light chain genes were less mutated. Mutational patterns in the V(H) genes did not reveal a conventional role for antigen in selection of tumor cell sequences in 23/25 V(H) genes analysed. In contrast, patterns in V(L) sequences were consistent with a role for antigen in 8/13 sBL +/- eBL cases and 8/17 cases overall. The presence of EBV did not seem to influence the quantity or pattern of somatic mutations. Evidence for intraclonal variation was seen in uncloned cell lines from cases of eBL and AIDS-associated BL and confirmed in biopsy material in some, but not all cases of eBL, sBL and AIDS-associated BL examined. These common features indicate that the B-cells involved in all types of BL are derived from cells that have traversed the germinal centre, and that the somatic mutation mechanism may still be operative following neoplastic transformation. Overall, in 10/30 cases, there was evidence of significant clustering of replacement amino acids, in CDRs, particularly in V(L), indicating that the B-cell of origin is likely to have been selected by antigen.
对V(H)和V(L)基因的使用情况以及体细胞突变的程度和模式进行分析,已被用于研究伯基特淋巴瘤(BL)病例中的细胞起源和克隆历史。对地方性、散发性和艾滋病相关BL患者的肿瘤细胞系和活检材料进行了比较。V(H)基因最常见地来源于V(H)3家族(52%)和V(H)4家族(39%)。这表明V(H)3家族的基因使用情况与正常外周血库中的情况相似(55%),但V(H)4家族的使用存在偏差(正常情况下为22%)。V(L)基因的使用没有限制。这种总体分布在BL的所有亚组中相似。在所有类别中,V(H)和V(L)序列中均存在显著的体细胞突变。没有证据表明体外培养的细胞系中存在突变积累,这表明BL来源的细胞系中的所有突变均在体内积累。地方性BL(V(H)=7.7±4.0,V(L)=5.3±2.2)和艾滋病相关BL(V(H)=7.5±3.6,V(L)=3.9±1.9)的平均突变百分比水平±标准差高于散发性BL(V(H)=4.0±2.5,V(L)=2.2±1.2)。不同类型BL的V(H)和V(L)序列中的体细胞超突变模式相似,尽管轻链基因的突变较少。在分析的23/25个V(H)基因中,V(H)基因的突变模式未揭示抗原在肿瘤细胞序列选择中的传统作用。相比之下,在8/13例散发性BL±地方性BL病例以及总体8/17例病例中,V(L)序列的模式与抗原的作用一致。EBV的存在似乎不影响体细胞突变的数量或模式。在地方性BL和艾滋病相关BL病例的未克隆细胞系中观察到克隆内变异的证据,并在一些(但不是所有)检查的地方性BL、散发性BL和艾滋病相关BL的活检材料中得到证实。这些共同特征表明,所有类型BL中涉及的B细胞均来源于已经穿过生发中心的细胞,并且体细胞突变机制在肿瘤转化后可能仍然起作用。总体而言,在10/30例病例中,有证据表明在互补决定区(CDR),特别是在V(L)中,替换氨基酸存在显著聚集,这表明起源的B细胞可能已被抗原选择。